Xie et al. (12) proposed a new APM model (AUC:0.790, 95% confidence interval [CI]: 0.740 ~ 0.834) including AFP levels to predict 28-day survival in patients with hepatitis B virus-related chronic plus acute liver failure treated with an artificial liver support system. The gene discussed is AFP; the disease is acute liver failure.